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ecent studies have suggested that neuronal death
in Alzheimer’s disease or ischemia could arise
from dysfunction of the endoplasmic reticulum (ER).
Although caspase-12 has been implicated in ER stress-
induced apoptosis and amyloid-
 
 
 
 (A
 
 
 
)–induced apoptosis
in rodents, it is controversial whether similar mechanisms
operate in humans. We found that human caspase-4, a
member of caspase-1 subfamily that includes caspase-12,
is localized to the ER membrane, and is cleaved when cells
are treated with ER stress-inducing reagents, but not with
other apoptotic reagents. Cleavage of caspase-4 is not
R
 
affected by overexpression of Bcl-2, which prevents signal
transduction on the mitochondria, suggesting that caspase-4
is primarily activated in ER stress-induced apoptosis.
Furthermore, a reduction of caspase-4 expression by small
interfering RNA decreases ER stress-induced apoptosis
in some cell lines, but not other ER stress-independent
apoptosis. Caspase-4 is also cleaved by administration of
A
 
 
 
, and A
 
 
 
-induced apoptosis is reduced by small interfering
RNAs to caspase-4. Thus, caspase-4 can function as an ER
stress-speciﬁc caspase in humans, and may be involved in
pathogenesis of Alzheimer’s disease.
 
Introduction
 
Recently, it has been reported that some human diseases,
such as Alzheimer’s disease (AD), Parkinson’s diseases, and
cystic fibrosis, and neuronal damage by ischemia are related
to stress acting on the ER, which leads to intraluminal accu-
mulation of unfolded proteins (Katayama et al., 1999; Wigley
et al., 1999; Imai et al., 2000, 2001; Nakagawa et al., 2000;
Sato et al., 2001; Tamatani et al., 2001). Stress on the ER
can be induced in vitro by depletion of calcium from the ER
lumen, inhibition of asparagine N-linked glycosylation,
reduction of disulfide bonds, expression of mutant proteins,
and ischemia (Imaizumi et al., 2001). ER stress induces
three major cellular responses: unfolded protein response
(UPR), ER-associated degradation, and apoptosis. Cells
exposed to ER stress can up-regulate genes encoding chaper-
ones that facilitate the protein folding process in the ER and
reduce overall translation (UPR; Harding et al., 1999;
Kaufman, 2002; Forman et al., 2003), or enhance proteasomal
degradation of misfolded ER protein in cytosol (Bonifacino
and Weissman, 1998; Travers et al., 2000), to reduce the
accumulation and aggregation of misfolded proteins, and
relieve cells from the stress (Kozutsumi et al., 1988). On
the other hand, excessive or long-termed ER stress results
in apoptotic cell death, involving nuclear fragmentation,
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condensation of chromatin, and shrinkage of the cell body
(Imaizumi et al., 2001). Several mechanisms that activate
apoptotic signaling pathways have been reported. For ex-
ample, the UPR increases the transcription of CHOP/
GADD153 (Brewer et al., 1997), which is closely associated
with cell death (Zinszner et al., 1998), recruitment of tumor
necrosis factor receptor–associated factor 2 (TRAF2) to acti-
vated IRE1
 
 
 
 induces c-Jun NH
 
2
 
-terminal kinase activation
(Urano et al., 2000), or calpain activates downstream cas-
pase cascade (Nakagawa and Yuan, 2000). However, little is
known about the precise mechanisms to lead to ER stress-
induced cell death in humans.
Activation of caspases, a family of cysteine proteases that
cleave substrates at specific aspartate residues, is a central
mechanism in the apoptotic cell death process (Salvesen
and Dixit, 1997; Thornberry and Lazebnik, 1998). Most
of apoptosis-inducing stimuli lead to release of cytochrome
 
c
 
 from mitochondria, which binds to Apaf-1 to activate
caspase-9 (Li et al., 1997; Zou et al., 1997), one of initiator
caspases with a long pro-domain, and then the activated cas-
pase-9 cleaves effector caspases (Li et al., 1997), including
caspases 3 and 7 with a relatively short pro-domain, to
activate them. Antiapoptotic Bcl-2 family proteins can res-
cue cells from apoptosis by protecting mitochondria to pre-
vent cytochrome 
 
c
 
 release (Kluck et al., 1997; Yang et al.,
1997). Several initiator caspases are known to be activated
upstream of the mitochondrial dysfunction by specific ap-
optotic stimuli. For example, Fas stimulation can activate
caspase-8 (Fernandes-Alnemri et al., 1996; Muzio et al.,
1996), which cannot be inhibited by Bcl-2 (Scaffidi et
al., 1998). Among 14 known caspases, caspase-12 seems to
be involved in signaling pathways specific to ER stress-
induced apoptosis (Nakagawa et al., 2000). Pro–caspase-12
is predominantly localized to the ER, and is specifically
cleaved by ER stress. Furthermore, caspase-12–deficient
mice show a reduced sensitivity to amyloid-
 
 
 
 (A
 
 
 
), which
is found in brains from Alzheimer’s patients (Selkoe, 1986)
and shown to cause neuronal cytotoxicity (Yankner et al.,
1989). Based on these findings, caspase-12 has been sug-
gested to play an important role in the pathogenesis of AD
and to represent a potential target of treatment. However,
caspase-12 has only been cloned in the mouse and rat so
far, and therefore it is controversial whether similar mecha-
nisms operate in humans (Katayama et al., 1999; Rao et al.,
2001; Fischer et al., 2002).
Human genome sequence that is highly homologous
to mouse caspase-12 has been identified at the locus
within the caspase-1/interleukin-1
 
 
 
 converting enzyme (ICE)
genes cluster on chromosome 11q22.3 (Fischer et al.,
2002), but the gene is interrupted by frame shift and pre-
mature stop codon, and also has amino acid substitution in
the critical site for caspase activity (Fischer et al., 2002).
Therefore, human caspase-12 seems to be lost, and the cas-
pases that substitute for caspase-12 to be activated specifi-
cally by ER stress have not been identified in humans so
far. We described here that human caspase-4 located
within the caspase-1/ICE genes cluster shows similar char-
acteristics to mouse caspase-12. The role of the caspase-4
in ER stress-induced apoptosis and A
 
 
 
-induced cell death
will be discussed.
 
Results
 
Identification of caspase-4 as a gene homologous 
to caspase-12
 
To detect a caspase that was specifically involved in ER
stress, we screened human colon cDNA libraries by the
plaque hybridization method using the mouse caspase-12
gene as a probe. Human caspase-4 was cloned as the most
homologous gene to mouse caspase-12, in agreement with
the fact that both molecules belong to the caspase-1/ICE
subfamily within the caspase family (Kamens et al., 1995;
Lin et al., 2000). Although caspase-5, which has slightly less
homology to caspase-12 (caspase-4: 48%; caspase-5: 45%),
was also isolated, the screening process yielded much more
caspase-4 clones than caspase-5. Because caspase-4 but not
caspase-5 was expressed in the cell lines used in this work,
which underwent apoptosis in response to ER stress, we as-
sumed that human caspase-4 might functionally substitute
for mouse caspase-12 in the human system, and further ana-
lyzed the possible role of caspase-4 as a mediator of ER
stress-induced apoptosis.
 
Subcellular localization of caspase-4
 
First, we studied the subcellular localization of endogenous
caspase-4 in SK-N-SH human neuroblastoma cells. Immu-
nofluorescence microscopy showed that immunostaining pat-
tern of caspase-4 strictly overlapped with that of ER markers
such as GRP78 and GRP94 (Fig. 1, a–c). Immunoreactivity
of caspase-4 was found to overlap only in part with fluores-
cence signals from Mitotracker (Fig. 1, d–f). These results
suggest that caspase-4 was localized predominantly to the ER,
and to the mitochondria in addition. The similar results were
obtained using HeLa cells (Fig. 1, g–l). When caspase-4 fused
with GFP at its COOH terminus was overexpressed in HeLa
cells to see the subcellular localization in live cells, most of the
fluorescent signals from caspase-4/GFP fusion protein over-
lapped with those from ER-tracker (Fig. 1, m–o), confirming
predominant localization of caspase-4 to the ER by non-
immunological method. The immunoelectron microscopic
analysis showed that the immunoreactive signals for caspase-4
were found on the ER and mitochondria (Fig. 1, p–r), but
much less signals on the nuclei (Fig. 1 r). We also performed
biochemical fractionation analysis. Although we could not
eliminate contamination of ER marker proteins in the mito-
chondria-enriched fraction using SK-N-SH cells, probably
because we could not disrupt cells homogeneously as the cell
line displays heterogeneity in cellular morphology, micro-
some-enriched fraction does not seem to contain mitochon-
dria and cytosol (Fig. 1 s). Under these conditions, caspase-4
was recovered in both mitochondria-enriched fraction and
microsome-enriched fraction, and in cytosolic fraction to a
lesser extent (Fig. 1 s), indicating that caspase-4 was surely in
microsome-enriched fraction. From these results, we con-
cluded that caspase-4 was localized to the ER, and to the mi-
tochondria in addition, in both SK-N-SH and HeLa cells.
 
Specific cleavage of caspase-4 by ER stress 
and A
 
 
 
 treatments
 
To examine whether caspase-4 was specifically cleaved by
ER stress, we analyzed the cleavage of pro–caspase-4 in re- 
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sponse to several apoptotic stimuli (Fig. 2 a). We found
that cleavage of pro–caspase-4 was induced in SK-N-SH
cells by treatment with tunicamycin and thapsigargin, both
of which caused ER stress. In contrast, when cells were ex-
posed to non-ER stress inducers such as etoposide, stauro-
sporine, and UV at a dose providing similar extent of cell
death to that by tunicamycin and thapsigargin, final cleav-
age products of pro–caspase-4 (Fig. 2 a, cleaved-caspase-4,
arrowhead) was not observed. Although the bands shown
by the asterisks in Fig. 2 a, which should be derived from
pro–caspase-4 by unknown processing reaction, judging
from the data below (Fig. 4 b), were also increased, they
were also observed in nontreated cells, so we speculated
that the bands were not the final processed form of cas-
pase-4. Under the same conditions, cleavage of caspases 3
and 7, the downstream caspases, was observed regardless of
apoptotic stimulations (Fig. 2 a). These results suggest that
caspase-4 is specifically activated by apoptotic stimuli in-
ducing ER stress, but not by other stimuli that do not
cause ER stress.
Figure 1. Localization of caspase-4 in SK-N-SH 
and HeLa cells. (a–l) SK-N-SH cells (a–f) or HeLa 
cells (g–l) were stained with anti–caspase-4 and 
anti-KDEL antibodies (a and g, caspase-4, green; 
b and h, KDEL, red; c and i, overlapping, yellow), 
or with anti–caspase-4 antibody and Mitotracker 
(d and j, caspase-4, green; e and k, Mitotracker, red; 
f and l, overlapping, yellow), and observed under a 
confocal microscope as described in Materials and 
methods. Anti-KDEL antibody detects both GRP78 
and GRP94 (ER markers), whereas Mitotracker stains 
the mitochondria. (m–o) HeLa cells were transfected 
with a caspase-4–GFP fusion gene, and were stained 
with ER-tracker (m, caspase-4, green; n, ER-tracker, 
blue; o, overlapping, blue-green), and observed 
under a nonconfocal fluorescence microscope. 
Bars, 5  m. (p and q) Immunoelectron microscopic 
analysis was performed for SK-N-SH cells as 
described in Materials and methods. Photograph 
shown in panel q is the enlarged image of a part of 
photograph p. Gold grains showed the immunore-
activity of caspase-4, and blue and red arrows 
showed the ER and mitochondria, respectively. 
Bars: (p) 200 nm; (q) 90 nm. (r) Gold grains observed 
on indicated organelles in immunoelectron micro-
scopic analysis were counted and displayed. 
(s) Biochemical fractionation was performed as 
described in Materials and methods, and analyzed 
by Western blotting using the indicated antibodies. 
Lamin B1, nuclear marker; cytochrome c, mito-
chondrial marker; presenilin-1 NH2-terminal 
fragment (PS1 NTF), microsomal marker; and 
glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), cytosolic marker. 
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To address the possibility that caspase-4 contributes to the
mechanism of A
 
 
 
-induced cell death in humans, we exam-
ined the cleavage of caspase-4 in SK-N-SH cells after treat-
ment with A
 
 
 
. When cells were incubated with 25 
 
 
 
M
A
 
 
 
25-35
 
 or 5 
 
 
 
M A
 
 
 
1-40
 
, cleavage of caspase-4 was observed
(Fig. 2 b). In contrast, treatment of cells with the reverse
peptides (A
 
 
 
35-25
 
 and A
 
 
 
40-1
 
, respectively), which were not
toxic, did not induce the cleavage of caspase-4 (Fig. 2 c).
These results suggest that caspase-4 is activated by neuro-
toxic A
 
 
 
 treatment similar to ER stress-induced apoptosis.
 
Cleavage of caspase-4 in the presence of Bcl-2
 
To confirm that cleavage of caspase-4 was not due to other
caspases activated downstream of the mitochondrial path-
way, we examined the effect of overexpression of Bcl-2 and
Bcl-x
 
L
 
 on apoptosis induced by tunicamycin. Apoptotic nu-
clear morphological changes were induced by treatment of
vector transfectants of SK-N-SH and of HeLa cells with tu-
nicamycin for 30 h, but such changes were completely sup-
pressed by overexpression of Bcl-2 (Fig. 3) or Bcl-x
 
L
 
 (not de-
picted), indicating that the apoptotic signaling pathway
downstream of mitochondria was not operating in cells with
overexpression of these antiapoptotic proteins. However,
cleavage of caspase-4 after 16 h of tunicamycin treatment
was only slightly affected by overexpression of Bcl-2 (Fig. 3)
or Bcl-x
 
L
 
 (not depicted). These results suggested that cas-
pase-4 is largely activated before the activation of effector
caspases during ER stress-induced cell death.
 
Requirement of caspase-4 for ER stress- 
and A
 
 
 
-induced apoptosis
 
To determine whether caspase-4 is required for ER stress-
induced cell death, SK-N-SH cells that expressed endoge-
nous caspase-4 were transfected with small interfering RNA
(siRNA) to caspase-4 or GFP as a control. Immunofluores-
cence analysis showed that the amount of caspase-4 was sub-
stantially decreased by incubation for 60 h after transfection
with siRNA directed against caspase-4, but immunoreactivity
of caspase-4 was not affected by transfection with GFP-
siRNA, when compared with nontransfected cells (Fig. 4 a).
Western blot analysis also showed that the amount of caspase-4
was decreased by siRNA to caspase-4 (Fig. 4 b). These re-
Figure 2. Specific cleavage of caspase-4 by ER stress and A  treatment. (a) SK-N-SH cells were treated with 1  g/ml tunicamycin (TM), 
0.5  M thapsigargin (TG), 100  M etoposide (Etop), or 0.1  M staurosporine (STS) for indicated periods, or irradiated with 150 J/m
2 UV 
followed by incubation for indicated periods. Equal amounts of cell lysates (15  g) were analyzed by Western blotting using anti–caspase-4 
antibody (top), anti–caspase-3 antibody (second from top), anti–caspase-7 antibody (third from top), or anti– -actin antibody (bottom). Positions 
of pro–caspase-4, cleaved caspase-4, cleaved caspase-3, cleaved caspase-7, and  -actin are indicated. Extent of cell death assessed by MTS 
assay after incubation for indicated periods are also shown at the top of the gels. (b) SK-N-SH cells were treated with 25  M synthetic A 25-35 
or 5  M A 1-40 peptides for the indicated periods. Equal amounts of cell lysates (15  g) were analyzed by Western blotting using anti–caspase-4 
antibody (top) and anti– -actin antibody (bottom) as a control. Positions of pro–caspase-4, cleaved caspase-4, and  -actin are indicated. 
(c) SK-N-SH cells were treated with the reverse peptides (25  M A 35-25 and 5  M A 40-1, respectively) for the indicated periods, and cleavage 
of caspase-4 was examined as in panel b. (a–c) Bands marked by asterisks are likely to be derived from pro–caspase-4 by unknown processing 
reaction. 
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sults showed that the siRNA could diminish the amount of
caspase-4, and that the antibody used here specifically recog-
nized caspase-4 in immunohistochemical analysis.
We next examined the effect of decrease in caspase-4 level
by siRNA on ER stress-induced apoptosis. Assessment of cell
death on the basis of morphological changes showed that
 
 
 
60% of untransfected SK-N-SH cells were killed by treat-
ment with thapsigargin for 40 h. The extent of cell death was
unaffected by transfection with siRNA to GFP (Fig. 4 c). In
contrast, only 
 
 
 
30% of the cells died after being transfected
with caspase-4 siRNA and exposed to the same stimulation with
thapsigargin (Fig. 4 c). As shown in Fig. 4 b, treatment with
thapsigargin for 24 h yielded lower level of cleaved-caspase-4
in the cells transfected with caspase-4 siRNA than in the cells
transfected with GFP-siRNA. Because the amount of cleaved
caspase-4 shown in Fig. 4 b seemed to correlate with the ex-
tent of cell death in Fig. 4 c, incomplete inhibition of cell
death by transfection with caspase-4 siRNA could be due to
residual activity of caspase-4. These results indicate that cells
with decreased expression of caspase-4 become more resistant
to ER stress-induced cell death.
When cell death was examined by the MTS assay, treat-
ment with caspase-4 siRNA, but not with GFP-siRNA, in-
creased the resistance to ER stress-induced cell death (Fig. 4
d). The increase in the resistance to ER stress-induced cell
death was also observed when siRNA to caspase-4 with a dif-
ferent sequence (caspase-4 siRNA-b) was used (Fig. 4 d), in-
dicating that the effect was due to the decreased expression
of caspase-4, but not by a specific side effect of caspase-4
siRNA that might affect the expression of other genes. On
the other hand, the efficiency of cell death induced by eto-
poside treatment was not significantly affected by both cas-
pase-4 siRNAs (Fig. 4 d). Therefore, caspase-4 is likely to be
specifically involved in ER stress-induced cell death.
To know whether caspase-4 is involved in ER stress-
induced cell death in other cell lines, we examined the effect
of caspase-4 siRNA using HeLa cells. As shown in Fig. 4 e,
treatment of HeLa cells with caspase-4 siRNA significantly
increased the resistance to ER stress-induced cell death, al-
though the extent of the increase in resistance was less than
that observed for SK-N-SH cells. This is probably because
some other apoptotic mechanisms might also operate simul-
taneously in HeLa cells. Therefore, we concluded that cas-
pase-4 is likely to be involved in ER stress-induced cell death
at least in part in HeLa cells.
We next examined whether caspase-4 is involved in A
 
 
 
-
induced cell death. When treated with A
 
 
 
25-35
 
, SK-N-SH
cells transfected with caspase-4 siRNA showed significant re-
duction in cell death compared with the cells transfected
with GFP-siRNA (Fig. 4 f). From these results presented
here, we concluded that caspase-4 is involved in A
 
 
 
-induced
cell death, as well as in ER stress-induced cell death.
 
Discussion
 
It has been known that apoptotic morphological changes are
observed in cell death caused by ER stress (Imaizumi et al.,
2001). Caspases are activated to transmit apoptotic signals
transcending the difference in species (Alnemri et al., 1996).
In rodents, caspase-12 mediates apoptosis specifically in re-
sponse to ER stress (Nakagawa et al., 2000). Although hu-
man caspase-12 gene is transcribed into mRNA, mature cas-
pase-12 protein would not be produced, because the gene is
interrupted by frame shift and premature stop codon (Fi-
scher et al., 2002). Furthermore, it contains amino acid sub-
stitution in the critical site, which leads to loss of function in
several caspases (Fischer et al., 2002). Thus, human caspase-
12 does not seem to function in ER stress-induced apopto-
sis, and some other caspases with similar structure might
substitute functionally for caspase-12 in humans. The cas-
pase-12 gene is located within a region where caspase-1/ICE
subfamily genes cluster (caspases 1, 4, 5, 12 in human and
caspases 1, 11, 12 in mouse). No locus with a comparably
high homology to rodent caspase-12 could be found in the
human genome. Caspases 4 and 5 are located between cas-
pases 1 and 12 in human genome, whereas only caspase-11
is located between caspases 1 and 12 in mouse. Although it
is not known why the region in human genome contains
gene duplication, caspases 4 and 5 have been thought to
function similarly to caspases 11 and 12. Mouse caspase-11
Figure 3. No effect of Bcl-2 overex-
pression on ER stress-induced cleavage 
of caspase-4. (a) SK-N-SH cells (left) and 
HeLa cells (right) stably transfected with 
the vector or a Bcl-2 expression system 
were incubated with ( ) or without ( ) 
1  g/ml tunicamycin for 16 h. Equal 
amounts of cell lysates were analyzed by 
Western blotting using anti–caspase-4 
antibody (top) and anti–Bcl-2 antibody 
(bottom). Positions of pro–caspase-4, 
cleaved caspase-4, and Bcl-2 are indi-
cated. Asterisks show processed caspase-4 
as described in Fig. 2 a. (b) The indicated 
cells were treated with 1  g/ml tunicamy-
cin for 30 h, stained with Hoechst 33342, 
and observed under a fluorescence 
microscope. Bars, 25  m. 
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is essential for the activation of caspase-1/ICE to promote
pro–IL-1
 
  
 
(interleukin-1
 
 
 
) processing (Wang et al., 1996,
1998). On the other hand, caspase-5 is likely involved in
processing of pro–IL-1
 
  
 
together with caspase-1/ICE (Mar-
tinon et al., 2002) and the caspase-5 gene resembles the
mouse caspase-11 in its lipopolysaccharide inducibility (Lin
et al., 2000). Therefore, caspase-5 should be the orthologue
of caspase-11. Here, the screening process yielded the cas-
pase-4 gene as the homologous gene to mouse caspase-12.
Thus, caspase-4 is the best candidate that would function
similarly to mouse caspase-12 in ER stress-induced cell
death in humans.
Figure 4. Decrease in ER stress- or A -induced cell death after siRNA-mediated reduction of caspase-4 expression. (a) SK-N-SH cells were 
transfected with siRNA oligos (1  g oligo/24 well plate) to GFP (control) or caspase-4 (siRNA-a). After incubation for 60 h, cells were fixed and 
stained with caspase-4 antibodies as described in Materials and methods. Bars, 5  m. (b) Cells were transfected as in panel a. After incubation 
for 60 h, cells were incubated with ( ) or without ( ) 0.5  M thapsigargin for 24 h. Equal amounts of cell lysates (10  g) were analyzed by 
Western blotting using anti–caspase-4 antibody (top) or anti– -actin antibody (bottom). (c) Top panels show representative phase-contrast 
images of GFP siRNA-transfected cells (left) and caspase-4 siRNA-a–transfected cells (right) after treatment with 0.5  M thapsigargin for 40 h. 
The bottom panel shows the extent of cell death assessed by morphological changes, and expressed as the mean   SEM for three independent 
experiments as described in Materials and methods. Asterisks show a significant difference from controls (GFP siRNA-transfected cells): **, 
indicates P   0.01. Bars, 50  m. (d) Cells were transfected with the indicated siRNAs, and cell viability after 0.5  M thapsigargin or 100  M 
etoposide treatment for 40 h was estimated by the MTS assay. Results were expressed as the mean   SEM for three independent experiments. 
Asterisks show a significant difference from controls: **, indicates P   0.01; ***, indicates P   0.001. Bottom panel shows reduction of 
caspase-4 level by the indicated siRNAs assessed by Western blotting as described in panel b. (e) HeLa cells were transfected with GFP siRNA 
or caspase-4 siRNA-a as described in Materials and methods. After incubation for 24 h, cells were incubated with 0.5  M thapsigargin for 40 h, 
and then viability was estimated as described in panel d. Each value represents the mean   SEM for three independent experiments. Asterisks 
show a significant difference from controls: ***, indicates P   0.001. (f) SK-N-SH cells were transfected with GFP siRNA or caspase-4 siRNA-a. 
After incubation for 60 h, cells were incubated with 25  M A 25-35 peptide for 40 h, and then viability was estimated as described in panel d. 
Each value represents the mean   SEM for three independent experiments. Asterisks show a significant difference from controls: **, indicates 
P   0.01.Caspase-4 in ER stress-induced apoptosis | Hitomi et al. 353
Here, we examined the localization of human caspase-4
using several methods. The immunostaining analysis using
anti–caspase-4 antibody and fluorescent analysis for cas-
pase-4/GFP fusion protein in Fig. 1 showed the predomi-
nant localization of caspase-4 on the ER. On the other
hand, the immuno-EM showed the nearly equal distribu-
tion of caspase-4 on the ER and mitochondria, and subcel-
lular fractionation showed that caspase-4 was recovered in
the microsome-enriched and mitochondria-enriched frac-
tions, and also in cytosolic fraction. Although we could not
eliminate contamination of ER marker proteins in the mi-
tochondria-enriched fraction in subcellular fractionation
using SK-N-SH cells, microsome-enriched fraction does
not seem to contain mitochondria and cytosol. Under these
conditions, caspase-4 was recovered in both mitochondria-
enriched fraction and microsome-enriched fraction, and
amounts of caspase-4 recovered in the microsome-enriched
and mitochondria-enriched fractions were comparable to
those of ER marker, presenilin-1. Therefore, considering all
the results shown in Fig. 1, we concluded that caspase-4 was
localized to the ER membrane, and probably to the mito-
chondria in addition.
Caspase-4 on the ER is supposed to function in ER stress-
induced apoptosis similarly to caspase-12. In supporting this
hypothesis, caspase-4 was cleaved specifically by ER stress
and A -treatment, but not by other apoptotic stimuli in-
cluding etoposide, staurosporine, and UV. Additionally
because Bcl-2 that can completely inhibit the signaling
pathway at least downstream from mitochondria, did not
prevent the cleavage of caspase-4 by ER stress, it should be
most probable that caspase-4 on the ER but not on mito-
chondria is primarily cleaved. We also showed that reduc-
tion of the level of caspase-4 by RNA interference (RNAi)
resulted in decrease in ER stress-induced cell death and A -
induced cell death, but did not affect cell death induced by
etoposide. The characteristics of human caspase-4 shown
here are very similar to those of mouse caspase-12 reported
previously (Nakagawa et al., 2000), and therefore, caspase-4
is able to substitute the caspase-12 functions in ER stress-
induced apoptosis and A -induced cell death. Because cas-
pase-4 was also localized to the mitochondria in addition to
the ER membrane, whereas caspase-12 was shown to localize
predominantly to the ER, but not to the mitochondria (Na-
kagawa et al., 2000), caspase-4 might have additional func-
tion compared with caspase-12, although the function of
caspase-4 on mitochondria is not clear.
Several mechanisms that activate caspase-12 have been
proposed in mouse system. For example, calpain, a protease
that can be activated by calcium released from ER upon ER
stress, starts cleavage of caspase-12 (Nakagawa and Yuan,
2000), caspase-7 activates caspase-12 upon prolonged ER
stress (Rao et al., 2001), or TRAF2 mediates caspase-12 acti-
vation, which is regulated by IRE1  (Yoneda et al., 2001).
It is not clear which mechanism is involved in activation of
caspase-4, but because final cleavage products were not ob-
served in cells with activated caspase-7 (Fig. 2 a), activation
of caspase-7 does not seem to be enough for full activation
of caspase-4. To know the precise mechanism that activate
caspase-4, it should be important to find proteins that inter-
act with pro–caspase-4 during ER stress-induced apoptosis.
The inhibition of apoptosis induced by ER stress expo-
sure by RNAi to caspase-4 was incomplete. It is possible
that the residual activity of caspase-4 after RNAi would be
responsible for the cell death. Alternatively, other apoptotic
mechanisms might also operate simultaneously. Several
possible pathways have been postulated for ER stress-
induced apoptosis. ER stress is reported to activate ASK–
c-Jun NH2-terminal kinase pathway through the IRE1–
TRAF2–ASK1 complex formation (Nishitoh et al., 2002).
Other signaling pathway is mediated by transcriptional acti-
vation of genes encoding proapoptotic function. Activation
of stress transducer IRE1, PERK, or ATF6 leads to tran-
scriptional activation of CHOP/GADD153, a bZIP tran-
scription factor that potentiates apoptosis (Oyadomari et
al., 2002). Operation of these mechanisms might account
for incomplete inhibition of ER stress-induced apoptosis by
knockout of caspase-12 and knockdown of caspase-4 in
mouse and humans, respectively. It is possible that caspase-
dependent mechanism and other mechanisms function in
parallel in initiating ER stress-induced apoptosis, and the
mechanism that mainly operates could differ depending on
cell types. We have shown that the extent to decrease in
cell death by decreasing caspase-4 level of SK-N-SH cells
was comparable to that reported for caspase-12 knockout
mouse (Nakagawa et al., 2000), whereas that of HeLa cells
was relatively less. We also find some cells, like HUVEC, in
which decrease in caspase-4 did not affect the ER stress-
induced apoptosis (unpublished data). Thus, caspase-4 has
been shown to function in ER stress-induced apoptosis at
least in several cell lines, including SK-N-SH and HeLa
cells, but not all cells.
Cell death caused by A  treatment was also partially in-
hibited by RNAi to caspase-4. Although it is controversial
whether A -induced cell death involves ER stress-induced
apoptosis, the results are consistent that these two types of
cell death are mediated by common mechanism at least in
part. Recent report described that the cell death induced by
A  was inhibited by the broad-spectrum caspase inhibitor
z-VAD and more specifically by the down-regulation of cas-
pase-2 with antisense oligonucleotides (Haviv et al., 1998).
Neuronal culture derived from caspase-2 null mice was also
shown to be partially resistant to A 1-42 toxicity (Troy et al.,
2000). Thus A 1-42-induced cell death might be mediated
by caspase-2 as well as caspase-12. It is possible that both
caspases 2 and 4 are involved in A -induced cell death also
in the human system.
Because caspase-4 seems to be responsible for cell death af-
ter A  treatment, caspase-4 might be involved in pathogene-
sis of AD. Consistently to this hypothesis, our preliminary
analysis showed an increase in cytoplasmic staining for cas-
pase-4 in the pyramidal cell layer of the hippocampal CA1-2
region in AD patients, but not in control brains (unpub-
lished data). All of the AD brains tested had stronger cas-
pase-4 immunoreactivity than disease control brains from
patients with other neurodegenerative disorders (n   4 for
AD and n   3 for disease control), and the strong staining
was remarkable in the pyramidal neurons around deposits of
 -amyloid. Increased caspase-4 might elevate the vulnerabil-
ity of neurons to apoptosis, and therefore may be involved in
the pathogenesis of AD.354 The Journal of Cell Biology | Volume 165, Number 3, 2004
Bcl-2 family proteins play essential roles in regulating
apoptosis. Although antiapoptotic family members (Bcl-2,
Bcl-xL) and multidomain proapoptotic members (Bak,
Bax) are thought to function mainly on mitochondria, re-
cent studies suggest that they may also function on the ER
where they reside as well. Overexpression of Bcl-2 (Foyouzi-
Youssefi et al., 2000; Pinton et al., 2000) or knockout of
both Bak and Bax (Scorrano et al., 2003) are reported to re-
duce ER Ca
2  concentration, but other reports showed that
Bcl-2 enhanced the retention of Ca
2  in the ER lumen (Dis-
telhorst et al., 1996; He et al., 1997). Thus, although it is
still controversial, Bcl-2 family members may contribute to
regulating ER stress-induced apoptosis on the ER (Ferri and
Kroemer, 2001; Scorrano et al., 2003; Zong et al., 2003) in
addition to their main function on mitochondria. Our re-
sults demonstrate that overexpressed Bcl-2 and Bcl-xL, which
can completely inhibit the signaling pathway at least down-
stream from mitochondria, did not prevent, but slightly af-
fected, the cleavage of caspase-4 by ER stress. The slight de-
crease might be due to the absence of its feed back cleavage
by downstream effector caspases, such as caspase-3. There-
fore, without regard to the mitochondria or the ER where
Bcl-2 family functions, activation of caspase-4 should be the
primary reaction in ER stress-induced activation of caspases.
In this work, we discovered that caspase-4 plays a key role
in ER stress-induced apoptosis in humans. Caspase-4 also
seems to act in the  -amyloid–induced cell death, suggesting
that human caspase-4 corresponds to rodent caspase-12 to
initiate cell death signaling pathway, and that the activation
of caspase-4 would mediate neuronal cell death in neurode-
generative disorder. Caspase-4 could be the potential target
to develop treatments for such diseases including AD.
Materials and methods
Chemicals and antibodies
We used the following antibodies: anti–caspase-4 mAb (4B9; MBL Interna-
tional Corporation), anti–caspase-4 pAb (Santa Cruz Biotechnology, Inc.),
anti-KDEL mAb (10C3; StressGen Biotechnologies), anti–Lamin B1 mAb
(L-5; Zymed Laboratories), anti–cytochrome c mAb (7H8.2C12; BD Bio-
sciences), anti–glyceraldehyde-3-phosphate dehydrogenase mAb (6G7; Bio-
genesis), anti–caspase-3 mAb (19; Transduction), anti–caspase-7 mAb (4G2;
MBL International Corporation), anti– -actin mAb (C4; CHEMICON Interna-
tional Inc.), anti–Bcl-2 mAb (#100; BD Biosciences), Alexa 588–conjugated
anti–mouse IgG antibody (Molecular Probes), FITC-conjugated anti–goat
IgG antibody (Jackson ImmunoResearch Laboratories), gold-conjugated
anti–goat IgG antibody (British BioCell), and HRP-conjugated anti–mouse
IgG antibody (Cell Signaling). Anti–presenilin-1 polyclonal antibody was
raised by immunizing rabbits with a synthetic peptide corresponding to resi-
dues 1–14 of human presenilin-1, and was affinity purified using ProtOn
Kit1 (MultiplePeptide Systems). The chemical reagents used in this experi-
ment were tunicamycin, thapsigargin, etoposide, staurosporine (Sigma-
Aldrich), and ER-tracker and Mitotracker (Molecular Probes). Cytotoxic pep-
tides, A 25-35 and A 1-40, and their reverse peptides, A 35-25 and A 40-1, were
purchased from Sigma-Aldrich.
Cell culture
Human neuroblastoma SK-N-SH cells and human carcinoma HeLa cells
were respectively cultured in  -MEM (Invitrogen) and DME (Invitrogen)
both containing 10% FBS, at 37 C under 5% CO2. For some experiments,
these cells were stably transfected with pCAGGS-hBcl-2 (Iwahashi et al.,
1997) and pCAGGS-hBcl-xL (Tagami et al., 2000) to overexpress Bcl-2 and
Bcl-xL, respectively.
cDNA cloning
A human colon cDNA library (Stratagene) was used for hybridization to iso-
lated cDNA homologous to the partial sequence of mouse caspase-12 gene.
Immunofluorescence microscopy
SK-N-SH cells or HeLa cells were incubated with or without Mitotracker
probes, and were fixed with 0.1 M phosphate buffer containing 4% PFA
for 2 h at 4 C. Cells were incubated with anti–caspase-4 pAb with or with-
out anti-KDEL mAb, followed by FITC- and Alexa 588–conjugated second-
ary antibodies, respectively. Stained cells were observed under a confocal
microscope (model LSM510; Carl Zeiss MicroImaging, Inc.). To determine
localization of caspase-4 in live cells, HeLa cells were transfected with
caspase-4/GFP fusion gene subcloned into a pcDNA3.1 (Invitrogen) to
produce caspase-4 fused with GFP at its COOH terminus, and after 24 h,
cells were incubated with ER-tracker probe for 30 min, followed by obser-
vation under a fluorescence microscope (model IX71; Olympus).
Immuno-EM
Immuno-EM was performed essentially as described previously (Miyake et
al., 2002). In brief, SK-N-SH cells cultured on a 15-cm dish were fixed
with 4% PFA in PBS, pH 7.2, at RT for several hours. After harvesting the
cells, they were washed with 30 mM Hepes buffer, pH 7.4, several times.
The cells were resuspended in 10% gelatin in 30 mM Hepes buffer, pH
7.4, at 37 C. After centrifugation to recover cells, gelatin was solidified on
ice. Blocks for ultracryotomy were prepared and infused with 20% polyvi-
nylpyrrolidone/1.84 M sucrose overnight at 4 C. Ultrathin sections were
collected on nickel grids and immunostained with anti–caspase-4 pAb.
The sections were incubated with gold-conjugated anti–goat IgG antibody
(gold particles, 10-nm diam) for 1 h at RT. Grids were contracted in 2%
uranyl acetate and examined on a transmission electron microscope
(model CM10; Philips).
Subcellular fractionation
SK-N-SH cells cultured on a 15-cm dish were washed twice with PBS, har-
vested, and suspended in buffer A (50 mM Tris-HCl, pH 8.0, 1 mM EDTA,
0.32 M sucrose, 0.1 mM PMSF) for 5 min on ice. Then the cells were
passed through a 25-gauge needle 13 times and centrifuged at 500 g for 10
min to collect a crude nuclear pellet. The supernatant was centrifuged at
1,200 g for 10 min to yield a mitochondria-enriched pellet, which con-
tained mitochondria and microsome as shown in Fig. 1 s. This supernatant
was further centrifuged at 100,000 g for 60 min to yield a microsomal pel-
let and a cytosolic fraction. All of the pellets were dissolved in buffer A
containing 1% SDS. Equal volume of each fraction was subjected to West-
ern blotting as described below, using indicated antibodies.
Western blot analysis
Cells treated with the indicated reagents were washed with PBS, harvested,
and lysed in TNE buffer (10 mM Tris-HCl, pH 7.8, 1 mM EDTA, 150 mM
NaCl, 1 mM PMSF) containing 0.5% NP-40. Equal amounts of protein
were subjected to 12% SDS-PAGE and transferred to a PVDF membrane
(Millipore). The membrane was blocked with 5% BSA and was incubated
with each primary antibody, followed by incubation with an HRP-conju-
gated secondary antibody. Proteins were visualized with an ECL detection
system (Amersham Biosciences).
Preparation and transfection of siRNAs
The annealed double-stranded siRNAs listed below were obtained from
Dharmacon, and were used to decrease expression of caspase-4. Cas-
pase-4 siRNA-a: 5 -AAGUGGCCUCUUCACAGUCAUdTdT-3  (sense), 5 -
AAAUGACUGUGAAGAGGCCACdTdT-3  (antisense); caspase-4 siRNA-
b: 5 -AAGAUUUCCUCACUGGUGUUUdTdT-3  (sense), 5 -AAAAACAC-
CAGTGAGGAAATCdTdT-3  (antisense). For control, siRNA to GFP was
used. GFP siRNA: 5 -P-GGCUACGUCCAGGAGCGCACC-3  (sense), 5 -P-
UGCGCUCCUGGACGUAGCCUU-3  (antisense). These sequences were
not significantly homologous to genes other than caspase-4 or GFP by
BLAST search (NCBI). SK-N-SH cells were transfected at 50% confluence
in 24-well plastic plates with 1.0  g of each of the above siRNAs using
Transmessenger transfection reagent (QIAGEN) according to the manufac-
turer’s protocol. Transfected cells were incubated at 37 C for 60 h without
changing the medium. siRNAs were introduced into HeLa cells by elec-
troporation three times with 48-h intervals using Amaxa system according
to the manufacturer’s protocol. Efficiency of RNAi was measured by im-
munocytochemical analysis and Western blot analysis using anti–cas-
pase-4 antibody or anti– -actin antibody.
Cell viability assay
SK-N-SH cells or HeLa cells overexpressing Bcl-2 and Bcl-xL, or trans-
fected with siRNAs as above were treated with various reagents as indi-
cated. When using A 1-40, it was preincubated for 1 wk at 37 C to establish
its cytotoxicity. Cell death was assessed on the basis of cellular morpho-Caspase-4 in ER stress-induced apoptosis | Hitomi et al. 355
logical changes observed by phase-contrast microscopy or from nuclear
morphological changes detected by fluorescence microscopy after staining
the cells with 10  M Hoechst 33342. At least 500 cells were counted, and
the data was expressed as the mean   SEM from three independent exper-
iments and P values were calculated by t test. The MTS ([3-(4, 5-dimeth-
ylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium, inner salt]) assay was also performed to evaluate cell viability. After
treatment with apoptosis-inducing reagents, cells were coincubated with
MTS solution (Promega) for 1 h at 37 C. The amount of reduced MTS re-
leased from the viable cells was quantified by measuring the absorbance at
490 nm using a spectrophotometer. Results were expressed as a ratio (%)
of dead cells after treatments to those in control as above.
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